Copyright
©The Author(s) 2022.
World J Gastroenterol. Jul 7, 2022; 28(25): 2910-2919
Published online Jul 7, 2022. doi: 10.3748/wjg.v28.i25.2910
Published online Jul 7, 2022. doi: 10.3748/wjg.v28.i25.2910
Pancreatic diseases | Receptor type | Relevant mechanism | Effect | Ref. |
Acute pancreatitis | M3 | Receptor overexpression | Acinar cell hypersecretion | [49,50,52,55] |
Chronic pancreatitis | M3 | Cholinergic signaling increases | Acinar cell hypersecretion | [13,64-66] |
M3/M5 | Receptor overexpression | Induce fibroblast proliferation | [92] | |
α7 | Enhances the autophagic flux of acinar cells | Inhibit acinar cell damage | [70,74-77] | |
Pancreatic cancer | M1 | Inhibition of the EGFR/MAPK and PI3K/AKT signaling pathways | Inhibit the progression of pancreatic tumors | [14] |
M3 | Receptor overexpression | Induction of preinvasive ductal tumor formation | [90,92-94] | |
α7 | Activating the JAK2/STAT3 signaling pathway | Increasing the migration and invasion capabilities of tumor cells | [86,97,98] |
- Citation: Yang JM, Yang XY, Wan JH. Multiple roles for cholinergic signaling in pancreatic diseases. World J Gastroenterol 2022; 28(25): 2910-2919
- URL: https://www.wjgnet.com/1007-9327/full/v28/i25/2910.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i25.2910